<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940324-2-00055</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=84 g=1 f=1 --> Eligible Applicants  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Eligible applicants are public entities and nonprofit private  <!-- PJG 0012 frnewline --> entities that are: migrant health centers under Section 329 of  <!-- PJG 0012 frnewline --> the PHS Act; community health centers under Section 330 of the  <!-- PJG 0012 frnewline --> PHS Act; health care for the homeless grantees under Section 340  <!-- PJG 0012 frnewline --> of the PHS Act; family planning grantees under Section 1001 of  <!-- PJG 0012 frnewline --> the PHS Act other than States; comprehensive hemophilia  <!-- PJG 0012 frnewline --> diagnostic and treatment centers; federally-qualified health  <!-- PJG 0012 frnewline --> centers under section 1905( <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> 1 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> )(2)(B) of the Social Security Act;  <!-- PJG 0012 frnewline --> or public and private nonprofit entities that currently provide  <!-- PJG 0012 frnewline --> comprehensive primary care services to populations at risk of HIV  <!-- PJG 0012 frnewline --> disease.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Funding under this grant program is intended to increase the  <!-- PJG 0012 frnewline --> capacity and accessibility of the specified entities to offer a  <!-- PJG 0012 frnewline --> higher quality and a broader scope of HIV-related early  <!-- PJG 0012 frnewline --> intervention services to a greater number of people in their  <!-- PJG 0012 frnewline --> service areas who are at risk of HIV infection. The program must  <!-- PJG 0012 frnewline --> provide the services specified in the statute (sections 2651,  <!-- PJG 0012 frnewline --> 2661, 2662) and may provide for a set of other optional services.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> The required services to be provided under this grant are:  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> &bull;Comprehensive individual counseling regarding HIV disease  <!-- PJG 0012 frnewline --> according to specific statutory mandates for the content  <!-- PJG 0012 frnewline --> and conduct of pretest counseling, counseling of those  <!-- PJG 0012 frnewline --> with negative test results, counseling of those with  <!-- PJG 0012 frnewline --> positive results, and with attention to the appropriate  <!-- PJG 0012 frnewline --> setting for all counseling;  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> &bull;Testing individuals with respect to HIV disease, in  <!-- PJG 0012 frnewline --> laboratories certified by the Clinical Laboratories  <!-- PJG 0012 frnewline --> Improvement Amendments, including tests to confirm the  <!-- PJG 0012 frnewline --> presence of the disease, tests to diagnose the extent of  <!-- PJG 0012 frnewline --> the deficiency in the immune system, and tests to provide  <!-- PJG 0012 frnewline --> information on appropriate therapeutic measures for  <!-- PJG 0012 frnewline --> preventing and treating the deterioration of the immune  <!-- PJG 0012 frnewline --> system and for preventing and treating conditions arising  <!-- PJG 0012 frnewline --> from the disease;  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> &bull;Referral to appropriate providers of health and support  <!-- PJG 0012 frnewline --> services, including, as appropriate to entities funded  <!-- PJG 0012 frnewline --> under parts A and B of title XXVI of the PHS Act, to  <!-- PJG 0012 frnewline --> biomedical research facilities, community-based  <!-- PJG 0012 frnewline --> organizations or other entities that offer experimental  <!-- PJG 0012 frnewline --> treatment for HIV disease, and to grantees under 2671 for  <!-- PJG 0012 frnewline --> the care of pregnant women;  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> &bull;Other clinical and diagnostic services regarding HIV  <!-- PJG 0012 frnewline --> disease, and periodic medical evaluations of individuals  <!-- PJG 0012 frnewline --> with the disease; and  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> &bull;Providing therapeutic measures for preventing and  <!-- PJG 0012 frnewline --> treating the deterioration of the immune system and for  <!-- PJG 0012 frnewline --> preventing and treating conditions arising from the  <!-- PJG 0012 frnewline --> disease.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Optional services that may be included if they can be shown to be  <!-- PJG 0012 frnewline --> essential to the delivery of care are:  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> &bull;Outreach, case management, and counseling for eligibility  <!-- PJG 0012 frnewline --> for other health services.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Applicants, or providers acting under an agreement with the  <!-- PJG 0012 frnewline --> applicant, must be participating and qualified providers under  <!-- PJG 0012 frnewline --> the State Medicaid plan approved under title XIX of the Social  <!-- PJG 0012 frnewline --> Security Act; a waiver procedure is available from BPHC.  <!-- PJG 0012 frnewline --> Grantees are required to maximize service reimbursements from  <!-- PJG 0012 frnewline --> private insurance, Medicare, other Federal programs, and other  <!-- PJG 0012 frnewline --> third-party payment sources.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            